IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q2 2022 Holdings

Filed 2022-08-15 | 33 holdings | $284.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$170.8M2,061,37360.1%
Biogen Inc(BIIB)COM09062X103$73.6M360,98125.9%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$23.6M1,678,1968.3%
Align Technology Inc(ALGN)COM016255101$10.5M44,3053.7%
Cytokinetics Inc(CYTK)COM23282W605$4.4M111,7171.5%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$642.0K160,8000.2%
United Therapeutics Corp(UTHR)COM91307C102$149.6K634,8060.1%
Abiomed Inc(ABMDEUR)COM003654100$122.4K494,3970.0%
Insmed Inc(INSM)COM457669307$115.2K5,840,3980.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$105.8K9,847,7740.0%
Staar Surgical Co(STAA)COM852312305$78.5K1,106,5670.0%
Revance Therapeutics Inc(RVNCEUR)COM761330109$60.9K4,405,0390.0%
Prothena Corp PLC(PRTA)COMG72800108$45.7K1,681,4770.0%
Sage Therapeutics Inc(SG7)COM78667J108$27.5K851,4090.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$27.2K2,491,2000.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$25.4K5,621,5330.0%
Alkermes PLC(ALKS)COMG01767105$18.0K603,4000.0%
Ehealth Inc(EHTH)COM28238P109$15.4K1,654,6930.0%
Gossamer BIO Inc(GOSS)COM38341P102$14.7K1,750,6510.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$11.8K612,6000.0%
Epizyme Inc(EPZMEUR)COM29428V104$10.0K6,774,5410.0%
Anaptysbio Inc(ANAB)COM032724106$8.8K431,0240.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$8.1K4,473,9670.0%
Gritstone Oncology Inc(2JQ)COM39868T105$5.6K2,330,5040.0%
Kezar Life Sciences IncCOM49372L100$5.4K656,2000.0%
Travere Therapeutics Inc(TVTX)COM89422G107$4.0K166,0690.0%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$1.3K64,7000.0%
Alimera Sciences IncCOM016259202$1.1K200,9190.0%
Novavax Inc(NVAX)COM670002401$64312,5000.0%
Magenta Therapeutics IncCOM55910K108$519432,3000.0%
Urogen Pharma LTD(URGN)COMM96088105$20124,5000.0%
Tactile Systems Technology I(TCMD)COM87357P100$19827,1000.0%
Marinus Pharmaceuticals Inc(MRNS*)COM56854Q200$15231,3300.0%